Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001266485 | SCV001444660 | uncertain significance | Inborn genetic diseases | 2017-12-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001322048 | SCV001512900 | uncertain significance | GLUT1 deficiency syndrome 1, autosomal recessive | 2022-02-20 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this missense change does not substantially affect SLC2A1 function (PMID: 23280796). This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 51 of the SLC2A1 protein (p.Arg51His). This variant is present in population databases (rs201815571, gnomAD 0.0009%). This missense change has been observed in individual(s) with clinical features of SLC2A1-related conditions (PMID: 31737037). ClinVar contains an entry for this variant (Variation ID: 985526). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SLC2A1 protein function. |
Fulgent Genetics, |
RCV002504382 | SCV002816990 | uncertain significance | Hereditary cryohydrocytosis with reduced stomatin; Dystonia 9; Encephalopathy due to GLUT1 deficiency; Childhood onset GLUT1 deficiency syndrome 2; Epilepsy, idiopathic generalized, susceptibility to, 12 | 2021-07-20 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003446670 | SCV004173605 | uncertain significance | Epilepsy, idiopathic generalized, susceptibility to, 12 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003446669 | SCV004173606 | uncertain significance | Dystonia 9 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003446667 | SCV004173607 | uncertain significance | Encephalopathy due to GLUT1 deficiency | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003446668 | SCV004173608 | uncertain significance | Childhood onset GLUT1 deficiency syndrome 2 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003446671 | SCV004173609 | uncertain significance | Hereditary cryohydrocytosis with reduced stomatin | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Clinical Genetics Laboratory, |
RCV004697096 | SCV005198270 | uncertain significance | not provided | 2022-08-12 | criteria provided, single submitter | clinical testing |